117 Poster <strong>Chemosensory</strong> Coding and ClinicalEARLY POSTNATAL ALCOHOL EXPOSURE REDUCED THESIZE OF THE NUCLEUS OF THE SOLITARY TRACT (NST) INNEONATAL RAT PUPSLi C.X. 1 , Maier S.E. 2 , Brasser S.M. 1 , Waters R.S. 1 1 Anatomy andNeurobiology, University of Tennessee Health Science Center,Memphis, TN; 2 NIAAA, NIH, Rockville, MDIntroduction: A strong association exists between alcohol ingestionand sucrose responsive neurons in rat NST (Lemon et al. 2004). Here,we examined the effect of postnatal alcohol exposure on the size ofNST in rat pups examined on postnatal day 10 (P10). Methods: Pupsobtained from untreated and normally conceived Sprague-Dawley damswere randomly assigned to alcohol (EtOH), pair-fed (PF), and untreated(UC) groups. EtOH pups received 6 g/kg dosage of alcohol while PFpups received isocaloric maltose-dextrin solution from P4–P9. EtOHand PF pups were treated daily (binge model) through a gastrostomytube implanted for artificial rearing. On P10, pups were sacrificed,brains removed and weighed, brainstem blocked, cut along a sagittalplane, and sections stained with cytochrome oxidase. The NST wasdigitized, reconstructed in Photoshop 7.0, and NST size measured usingImageJ. Body weight was also examined over postnatal days. Results:The total area of NST in EtOH pups (mean area = 0.32 mm 2 ) wassignificantly smaller (p < 0.5) compared to PF (mean area = 0.39 mm 2 )controls. Normalization of the data (EtOH vs PF) revealed a 16%reduction of total NST in EtOH pups. Similarly, normalized body andbrain weights of EtOH pups were 12% and 25% lower compared to PFpups, respectively. Conclusion: The present results suggest that earlyalcohol exposure results in detrimental effects on developing NST.(Supported by NIAAA, R01 AA013437 to R.S.W., and AA10090 to J.West)118 Poster <strong>Chemosensory</strong> Coding and ClinicalLACTISOLE GREATLY DECREASES DIFFERENTIALTHRESHOLDS FOR SUCROSE: A CASE FOR INCREASEDCOOPERATIVITYGalindo-Cuspinera V. 1 , Tharp A.A. 1 , Winnig M. 2 , Bufe B. 2 , MeyerhofW. 2 , Breslin P.A. 1 1 Monell Chemical Senses Center, Philadelphia, PA;2 German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal,GermanyWe have previously demonstrated that adaptation to a taste stimulusresults in increased sensitivity, despite decreasing the overall perceivedintensity. Here, we demonstrate that the addition of a taste inhibitor canalso lead to increased differential sensitivity. Lactisole, a broad-actingsweetness inhibitor, suppresses the sweet taste of sugars, proteinsweeteners, and artificial sweeteners. Lactisole's inhibitory effect isspecific to primates and does not affect responses to sweet compoundsin rodents. Here we show by using two different psychophysicalmethods, Weber fractions and psychometric functions, that lactisoleadded in small amounts greatly increases differential sensitivity tosucrose, reducing Weber fractions to as low as 0.25%. Some subjectswere able to distinguish 400 from 401 mM sucrose. We observed thatlactisole acts as an inverse agonist by studying, in vitro, its interactionwithin the intrinsically active hTAS1R2-hTAS1R3 sweetener receptorheteromer. The presence of an inverse agonist, lactisole, could enablean increased cooperativity of sucrose molecules when binding to thehTAS1R2-hTAS1R3 receptor, which would explain the greatlyincreased differential sensitivity to sucrose observed in the presence oflactisole. Suported by PASB NIH DC02995 and NIHP50DC0670119 Poster <strong>Chemosensory</strong> Coding and ClinicalEFFECTS OF PREGNANCY ON OLFACTIONCameron E.L. 1 1 Carthage College, Kenosha, WIReports of changes in olfactory sensitivity during pregnancy havebeen inconsistent, but hedonic ratings do appear to change. Odoridentification is unaffected by pregnancy, but the range of odors testedhas been limited. The current study tested 30-18- to 45-year-old nonsmokingwomen (15 pregnant, equally divided across trimester, and 15age-matched controls) on the 40-item UPSIT. Intensity ratings andnumber of scratches and sniffs were collected as indicators ofsensitivity, and participants rated the pleasantness of each odor.Participants also rated their own sense of smell. Mean UPSIT scoreswere 35.4 (pregnant) and 35.5 (controls), indicating no difference inodor identification for a large range of odors. Pregnant women ratedtheir sense of smell significantly higher than controls (Wilcoxon test),and trends suggest that they used fewer scratches and sniffs per odor,potentially confirming their self-reports. Between groups, meanintensity and pleasantness ratings approached significance; 87% ofodors were rated as slightly more intense and 67% as less pleasant bypregnant women. Consistent with previous reports, over 90% ofpregnant women reported that specific odors smell less pleasant (e.g.,meat and smoke) and about 75% reported that some odors smell morepleasant (e.g., fruit). In conclusion, pregnant women report that theirodor sensitivity is enhanced during pregnancy and appear to need toscratch and sniff less often in order to identify odors on the UPSIT.Moreover, pregnant women show enhanced intensity and hedonicratings. Odor identification, however, is unchanged. These data are partof an on-going study that will examine trimesters and postpartumphases separately.120 Poster <strong>Chemosensory</strong> Coding and ClinicalNICOTINE SUPPRESSION OF TASTE AND GUSTATORYRESPONSES OF NTS NEURONSSimons C.T. 1 , Boucher Y. 2 , Albin K. 3 , Iodi Carstens M. 3 , Carstens E. 31 Givaudan Flavors Global R&D, University of California, Davis,Cincinnati, OH; 2 Université Paris 7, Paris, France; 3 Neurobiology,Physiology and Behavior, University of California, Davis, Davis, CASmokers weigh less than nonsmokers and gain weightdisproportionately upon quitting. We investigated the hypothesis thatthe anorectic effect of nicotine in tobacco is mediated partly by areduction in the intensity of and preference for certain tastes viadepression of central gustatory transmission. In psychophysicalexperiments using a sensitive two-alternative forced choice methodcoupled with magnitude ratings of taste on each side of the tongue,nicotine reduced the perceived intensity of sweet and bitter tastequalities and reduced hedonic ratings of a naturally sweetened custard.The effect was transient and no longer present 5 min later after nicotineirritation had waned. In single-unit recordings from anesthetized rats,nicotine directly excited gustatory neurons in the nucleus of the solitarytract (NTS) and significantly attenuated their responses to the preferredtastant (sucrose, NaCl, citric acid or MSG) in a dose-dependent manner.Nicotinic excitation of NTS units, and depression of tastant-evokedresponses, were significantly attenuated by the nicotinic antagonistmecamylamine. Nicotine excited NTS units in rats in which trigeminalafferent input was blocked by ganglionectomy, but no longer depressedtastant-evoked responses, indicating that nicotine excites NTS unitsdirectly via taste nerves and inhibits their tastant-evoked responses by acentral trigeminally-mediated mechanism. The results are consistentwith the hypothesis that nicotine reduces food intake in part by aphysiologically mediated reduction in taste intensity and palatability.30
121 Poster <strong>Chemosensory</strong> Coding and ClinicalMULTIMODAL SENSORY STIMULATION OF THE NASALMUCOSA WITH NICOTINE—FMRI STUDYAlbrecht J. 1 , Kopietz R. 1 , Linn J. 1 , Sakar V. 1 , Anzinger A. 1 , SchrederT. 1 , Kobal G. 2 , Wiesmann M. 1 1 Dept. of Neuroradiology, University ofMunich, Munich, Germany; 2 Sensory Research R&T, Philip MorrisUSA Inc., Richmond, VAObjectives: No FMRI data are available on cortical activationsinduced by the effects of nicotine on the olfactory system. If applied tothe nasal mucosa in low concentration, nicotine evokes odoroussensations by activation of olfactory receptors. At higherconcentrations, trigeminal fibers are activated as well leading to burningor even stinging sensations. The aim of this study was to investigatebrain areas activated by nasal stimulation with nicotine at lowsuprathreshold olfactory concentrations. Methods: Nicotine wasapplied at suprathreshold concentration in 19 healthy subjects using aconstant-flow olfactometer (block-design) Functional images wereacquired using a 1.5T MRI scanner. Results and Conclusions: Wefound activation of brain areas known to be involved followingolfactory stimulation of the nasal mucosa (piriform cortex, orbitofrontalcortex, insula), as well as areas specific to the processing of emotions(amygdala, cingulum) and areas related to attention and memory(middle frontal gyri, superior parietal lobule). We also found activationsin areas specific to the processing of painful and aversive stimuli(ventroposterolateral thalamus, S2) indicating that nicotine is amultimodal stimulus which affects both olfactory and somatosensoryareas. In summary, even at low concentrations nicotine activates boththe olfactory and the trigeminal system. Research described in thisabstract was supported by Philip Morris USA Inc.122 Poster <strong>Chemosensory</strong> Coding and ClinicalTOKI-SHAKUYAKU-SAN IN THE TREATMENT OFSENSORINEURAL SMELL DYSFUNCTIONTsukatani T. 1 , Miwa T. 1 , Ikeno S. 1 , Yagi S. 1 , Furukawa M. 11 Otorhinolaryngology, Kanazawa University, Kanazawa, Ishikawa,JapanSteroid therapy is used in the treatment of sensorineural smelldysfunction such as viral infection of upper respiratory tract, howeverits efficacy is still considered controversial. Toki-shakuyaku-san (TSS)(Tsumura & Co., Tokyo, Japan), a Chinese herbal medicine, hasrecently been reported as effect in the treatment of Alzhimer´sdementia. The purpose of this study was to compare the clinical efficacyof TSS with local steroid therapy for sensorineural smell dysfunction.TSS was prescribed for 40 patients (28 with post viral infection and 12with head trauma) from 1998 to 2004. A group of 60 patients (46 withpost viral infection and 14 with head trauma) who received local steroidtherapy from 1993 to 1997 served as controls. For assessment ofolfactory function, T&T olfactometry was employed before and aftertreatment. Of the 28 post viral infections treated by TSS, 19 cases(67.9%) recovered completely or partially. This was significantly betterthan the efficacy for local steroid therapy (43.5%). For the head traumagroup, there was no significant difference between the efficacy of TSS(41.7%) and local steroid therapy (28.6%). Since local steroid therapyproduces side effects such as ACTH suppression and glucoseintolerance and TSS did not show any serious side effects, TSS mayprove to be a preferred therapy for smell dysfunction following viralinfection.123 Poster <strong>Chemosensory</strong> Coding and ClinicalTHE POTENTIAL EFFECT OF AMBIENT ARSENIC INDRINKING WATER ON ODOR IDENTIFICATION IN ANAGRICULTURAL SAMPLE IN INNER MONGOLIAPrah J.D. 1 , Mumford J. 2 , Li Y. 3 , Xia Y. 3 , Liu Y. 3 , Zhang F. 4 , Le X. 51 U.S. EPA, Chapel Hill, NC; 2 Human Studies Division, US EPA, ChapelHill, NC; 3 Inner Mongolia Center for Endemic Disease Control andResearch, Huhhot, Inner Mongolia, China; 4 Ba Men Anti-epidemicStation, Lin He, Inner Mongolia, China; 5 University of Alberta,Edmonton, Manitoba, CanadaThere is evidence that exposure to arsenic (As) can have neuropathicand neurosensory effects in humans. It is unknown if As affects thesense of smell. To determine if odor identification is impaired by Asexposure in drinking water, 308 persons in Inner Mongolia were giventhe Brief Smell Identification Test (BSIT). The mean score was 7.398.The age range was 10-61.The subjects were primarily farmers whodrink well water. The mean As concentration in drinking water was126.0 ìg/L( range 0.34 to 825.7). The drinking water standard in theUSA is 10 ìg/L. This resulted in mean urinary As2O3, As2O5,dimethylarsinic acid V (DMAV), and monomethylarsonic acid V(MMAV) levels of 53.75, 5.8, 201, and 53.4 ìg/L , respectively.Regression analyses of the BSIT score vs arsenic species indicates asignificant relationship between urinary As species and odoridentification. The p-values for the species are as: As2O3 p = 0.007;As2O5 p = 0.139; MMAV p = 0.016; DMAV p = 0.017. The regressionwith water As was not significant (p = 0.237). Thus, body burden is abetter predictor of effect than water concentration. It is possible that thevariability in quantity of water consumed which would alter the totaldose or that some persons metabolize inorganic As into more toxicmethylated species. The mechanism of the toxicity may reside in itschemotherapeutic usage. As2O3 is used to treat acute myeloid leukemiaand its efficacy is thought act by causing incomplete cytodifferentiationand subsequently inducing apoptosis. Neurogenesis of olfactoryreceptor cells may be similarly impaired by As compounds. This is anabstract of a proposed presentation and does not reflect EPA policy.Funded by EPA124 Poster <strong>Chemosensory</strong> Coding and ClinicalHETEROSEXUAL FEMALES, BUT NOT LESBIANS,SENSITIZE TO LOW LEVELS OF ODORANTWysocki C. 1 , Sergeant M. 2 , Louie J. 1 1 Monell Chemical Senses Center,Philadelphia, PA; 2 Division of Psychology, Nottingham TrentUniversity, Nottingham, United KingdomSexual orientation influences human olfaction (Martins et al, 2005,Psych. Sci.). Here we report that lesbians, like heterosexual males, donot demonstrate a gender-typical process of olfactory sensitization tolow level odorants previously reported for women, but not men (Daltonet al., 2002, Nat. Neurosci.). This finding suggests that within-gendervariation in sensitization among women may not be fully explained bychanges in levels of activational hormones.31
- Page 1 and 2: 1 Symposium Chemosensory Receptors
- Page 3 and 4: 9 Symposium Chemosensory Receptors
- Page 5 and 6: 17 Givaudan LectureFISHING FOR NOVE
- Page 7 and 8: 25 Symposium Impact of Odorant Meta
- Page 10 and 11: 37 Poster Peripheral Olfaction and
- Page 12 and 13: 45 Poster Peripheral Olfaction and
- Page 14 and 15: 53 Poster Peripheral Olfaction and
- Page 16 and 17: 61 Poster Peripheral Olfaction and
- Page 18 and 19: 69 Poster Peripheral Olfaction and
- Page 20 and 21: 77 Poster Peripheral Olfaction and
- Page 22 and 23: 85 Poster Peripheral Olfaction and
- Page 24 and 25: 93 Poster Chemosensory Coding and C
- Page 26 and 27: 101 Poster Chemosensory Coding and
- Page 28 and 29: 109 Poster Chemosensory Coding and
- Page 32 and 33: 125 Poster Chemosensory Coding and
- Page 34 and 35: 133 Poster Chemosensory Coding and
- Page 36 and 37: sniffing behavior. Furthermore, we
- Page 38 and 39: 149 Slide Chemosensory Coding and C
- Page 40 and 41: 157 Slide Taste ChemoreceptionHTAS2
- Page 42 and 43: 165 Poster Multimodal, Chemosensory
- Page 44 and 45: 173 Poster Multimodal, Chemosensory
- Page 46 and 47: 181 Poster Multimodal, Chemosensory
- Page 48 and 49: 189 Poster Multimodal, Chemosensory
- Page 50 and 51: 197 Poster Multimodal, Chemosensory
- Page 52 and 53: 205 Poster Multimodal, Chemosensory
- Page 54 and 55: 213 Poster Multimodal, Chemosensory
- Page 56 and 57: 221 Poster Multimodal, Chemosensory
- Page 58 and 59: 229 Slide Molecular Genetic Approac
- Page 60 and 61: 237 Poster Central Olfaction and Ch
- Page 62 and 63: 245 Poster Central Olfaction and Ch
- Page 64 and 65: 253 Poster Central Olfaction and Ch
- Page 66 and 67: 261 Poster Central Olfaction and Ch
- Page 68 and 69: 269 Poster Central Olfaction and Ch
- Page 70 and 71: 277 Poster Central Olfaction and Ch
- Page 72 and 73: 285 Poster Central Olfaction and Ch
- Page 74 and 75: 293 Poster Central Olfaction and Ch
- Page 76 and 77: 301 Slide Central OlfactionOLFACTOR
- Page 78 and 79: 309 Poster Chemosensory Molecular G
- Page 80 and 81:
317 Poster Chemosensory Molecular G
- Page 82 and 83:
325 Poster Chemosensory Molecular G
- Page 84 and 85:
333 Poster Chemosensory Molecular G
- Page 86 and 87:
341 Poster Chemosensory Molecular G
- Page 88 and 89:
349 Poster Chemosensory Molecular G
- Page 90 and 91:
357 Poster Chemosensory Molecular G
- Page 92 and 93:
365 Poster Chemosensory Molecular G
- Page 94 and 95:
373 Symposium Olfactory Bulb Comput
- Page 96 and 97:
381 Symposium Presidential: Why Hav
- Page 98 and 99:
389 Poster Central Taste and Chemos
- Page 100 and 101:
397 Poster Central Taste and Chemos
- Page 102 and 103:
405 Poster Central Taste and Chemos
- Page 104 and 105:
413 Poster Central Taste and Chemos
- Page 106 and 107:
421 Poster Central Taste and Chemos
- Page 108 and 109:
429 Poster Central Taste and Chemos
- Page 110 and 111:
437 Symposium Neural Dynamics and C
- Page 112 and 113:
445 Poster Developmental, Neurogene
- Page 114 and 115:
453 Poster Developmental, Neurogene
- Page 116 and 117:
461 Poster Developmental, Neurogene
- Page 118 and 119:
469 Poster Developmental, Neurogene
- Page 120 and 121:
477 Poster Developmental, Neurogene
- Page 122 and 123:
485 Poster Developmental, Neurogene
- Page 124 and 125:
493 Poster Developmental, Neurogene
- Page 126 and 127:
501 Poster Developmental, Neurogene
- Page 128 and 129:
Brody, Carlos, 438Brown, R. Lane, 3
- Page 130 and 131:
Gilbertson, Timothy Allan, 63, 64,
- Page 132 and 133:
Klouckova, Iveta, 150Klyuchnikova,
- Page 134 and 135:
Ni, Daofeng, 93Nichols, Zachary, 35
- Page 136 and 137:
Sorensen, Peter W., 23, 288, 289Sou
- Page 138:
Zeng, Musheng, 466Zeng, Shaoqun, 26